RBMS1 and cardiac hypertrophy: Our research findings indicate that genetic deletion or pharmacological inhibition of RBMS1 expression can alleviate cardiac hypertrophy, thereby confirming that RBMS1 is a promising therapeutic target for the treatment of cardiac hypertrophy and heart failure.